Effects of Remote Ischemic Conditioning on Blood Pressure in Older Patients With Hypertension
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Zhen-Ni Guo, MD, PhD
- Phone Number: 0086 18186872986
- Email: zhen1ni2@163.com
Study Contact Backup
- Name: Yi Yang, MD, PhD
- Phone Number: 0086 13756661217
- Email: doctor_yangyi@163.com
Study Locations
-
-
Jilin
-
Changchun, Jilin, China, 130000
- Recruiting
- First Hospital of Jilin University
-
Contact:
- Yi Yang, MD, PhD
- Phone Number: 0086 13756661217
- Email: doctoryangyi@163.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 1) Age ≥65 years and ≤85 years, regardless of gender;
- 2) History of essential hypertension and clinical systolic blood pressure ≥ 140 mmHg, regardless of whether they are receiving antihypertensive medication;
- 3) Willing to participate and sign the informed consent.
Exclusion Criteria:
- 1) Secondary hypertension;
- 2) Clinical blood pressure ≥ 180/110 mmHg or 24-hour mean arterial pressure ≥ 170/100 mmHg;
- 3) Severe organ dysfunction or failure;
- 4) Severe hematologic disorders or significant coagulation abnormalities;
- 5) History of atrial fibrillation or myocardial infarction within 6 months;
- 6) Individuals who had contraindication of remote ischemic conditioning, such as severe soft tissue injury, fracture or vascular injury in the upper limb, acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc;
- 7) Individuals who will or have received anticoagulant therapy with drugs such as dabigatran, rivaroxaban, warfarin, etc;
- 8) Those who are participating in other clinical research or has participated in other clinical research or has participated in this study within 3 months prior to enrollment;
- 9) Other conditions that the researchers think are not suitable for the project.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: RIC group
Patients are treated with remote ischemic conditioning (RIC).
|
Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of upper limb ischemia followed by 5 min reperfusion.
Limb ischemia was induced by the inflation of an automated cuff to the pressure rising by 20 mmHg from baseline systolic pressure.
RIC will be conducted twice daily for 7 days.
|
|
Placebo Comparator: Sham RIC group
Patients are treated with sham remote ischemic conditioning (sham-RIC).
|
Sham-RIC is performed in the same way as the treatment group except that the blood pressure cuff is inflated to 60 mmHg, which produces mild pressure sensations but has no blocking impact on blood flow.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean systolic blood pressure
Time Frame: 0-7 days
|
Difference in mean value of systolic blood pressure during RIC/sham-RIC between two groups.
|
0-7 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean diastolic blood pressure
Time Frame: 0-7 days
|
Difference in mean value of diastolic blood pressure during RIC/sham-RIC between two groups.
|
0-7 days
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RICBP-HT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.